88 related articles for article (PubMed ID: 23305838)
1. In vivo profile of the anticoagulant effect of 17ß-amino-1,3,5(10)estratrien-3-ol.
Lemini C; Rubio-Póo C; Franco Y; Jaimez R; Avila ME; Medina M; Lemus AE
Eur J Pharmacol; 2013 Jan; 700(1-3):210-6. PubMed ID: 23305838
[TBL] [Abstract][Full Text] [Related]
2. Contrasting effects of estradiol and 17 beta-aminoestrogens on blood clotting time in rats and mice.
Lemini C; Franco Y; Avila ME; Jaimez R
Eur J Pharmacol; 2005 Mar; 510(3):229-33. PubMed ID: 15763247
[TBL] [Abstract][Full Text] [Related]
3. Sub-acute effects of the 17beta-aminoestrogen pentolame and estradiol on hemostasis in the rat.
Lemini C
Proc West Pharmacol Soc; 2009; 52():57-60. PubMed ID: 22128424
[TBL] [Abstract][Full Text] [Related]
4. Changes on hemostatic parameters induced by 17beta-estradiol, ethinylestradiol, and the 17beta-aminoestrogen pentolame in the male Wistar rat.
García-Manzano A; González-Llaven J; Jaimez R; Franco Y; Estela Avila M; Rubio-Póo C; Lemini C
Steroids; 2002 Dec; 67(13-14):1129-35. PubMed ID: 12441199
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulant and estrogenic effects of two new 17 beta-aminoestrogens, butolame [17 beta-(4-hydroxy-1-butylamino)-1,3,5(10)-estratrien-3-ol] and pentolame [17 beta-(5-hydroxy-1-pentylamino)-1,3,5(10)-estratrien-3-ol].
Lemini C; Rubio-Póo C; Silva G; García-Mondragón J; Zavala E; Mendoza-Patiño N; Castro D; Cruz-Almanza R; Mandoki JJ
Steroids; 1993 Oct; 58(10):457-61. PubMed ID: 8256254
[TBL] [Abstract][Full Text] [Related]
6. Effects on blood clotting time of 17 beta-estradiol and 17 beta-aminoestrogens in rats and mice.
Jaimez R; Rubio-Póo C; Lemini C
Proc West Pharmacol Soc; 2001; 44():163-6. PubMed ID: 11793970
[No Abstract] [Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
8. In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate.
Wienen W; Stassen JM; Priepke H; Ries UJ; Hauel N
Thromb Haemost; 2007 Jul; 98(1):155-62. PubMed ID: 17598008
[TBL] [Abstract][Full Text] [Related]
9. SSR182289A, a novel, orally active thrombin inhibitor: in vitro profile and ex vivo anticoagulant activity.
Berry CN; Lassalle G; Lunven C; Altenburger JM; Guilbert F; Lalé A; Hérault JP; Lecoffre C; Pfersdorff C; Herbert JM; O'Connor SE
J Pharmacol Exp Ther; 2002 Dec; 303(3):1189-98. PubMed ID: 12438543
[TBL] [Abstract][Full Text] [Related]
10. Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity.
van Ryn J; Stangier J; Haertter S; Liesenfeld KH; Wienen W; Feuring M; Clemens A
Thromb Haemost; 2010 Jun; 103(6):1116-27. PubMed ID: 20352166
[TBL] [Abstract][Full Text] [Related]
11. In vitro effects of detergent sclerosants on coagulation, platelets and microparticles.
Parsi K; Exner T; Connor DE; Ma DD; Joseph JE
Eur J Vasc Endovasc Surg; 2007 Dec; 34(6):731-40. PubMed ID: 17919946
[TBL] [Abstract][Full Text] [Related]
12. Effects of anticoagulant from Spirodela polyrhiza in rats.
Cho HR; Choi HS
Biosci Biotechnol Biochem; 2003 Apr; 67(4):881-3. PubMed ID: 12784632
[TBL] [Abstract][Full Text] [Related]
13. Long duration of anticoagulant activity and protective effects of acharan sulfate in vivo.
Li DW; Lee IS; Sim JS; Toida T; Linhardt RJ; Kim YS
Thromb Res; 2004; 113(1):67-73. PubMed ID: 15081567
[TBL] [Abstract][Full Text] [Related]
14. Estrogenic effects of 17 beta-aminoestrogens assessed in uteri of rats and mice.
Lemini C; Franco Y; Avila ME; Jaimez R
Eur J Pharmacol; 2005 Mar; 510(3):235-9. PubMed ID: 15763248
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and pharmacological effects of the direct thrombin inhibitor AR-H067637.
Deinum J; Mattsson C; Inghardt T; Elg M
Thromb Haemost; 2009 Jun; 101(6):1051-9. PubMed ID: 19492147
[TBL] [Abstract][Full Text] [Related]
16. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.
Eerenberg ES; Kamphuisen PW; Sijpkens MK; Meijers JC; Buller HR; Levi M
Circulation; 2011 Oct; 124(14):1573-9. PubMed ID: 21900088
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulant activity of captopril.
Brecher AS; Murrey SJ; Gray KD; Poulimenos JN
J Cardiovasc Pharmacol; 2008 Jan; 51(1):99-105. PubMed ID: 18209575
[TBL] [Abstract][Full Text] [Related]
18. Effect of telavancin (Vibativ) on routine coagulation test results.
Gosselin R; Dager W; Roberts A; Freeman L; Gandy L; Gregg J; Dwyre D
Am J Clin Pathol; 2011 Dec; 136(6):848-54. PubMed ID: 22095369
[TBL] [Abstract][Full Text] [Related]
19. [Study of anticoagulant activity of ethanol extracts from leech in vitro].
Feng GJ; Zhu ZG; Yu CL; Zhang Q; Chen NN; Lei LS; Wu SG
Zhong Yao Cai; 2007 Aug; 30(8):909-11. PubMed ID: 18074833
[TBL] [Abstract][Full Text] [Related]
20. The anticoagulant effect of hexolame, N-(3-hydroxy-1,3,5(10)-estratrien-17 beta-yl)-6-hydroxyhexylamine, another amino-estrogen with prolonged anticoagulant effect.
Rubio-Póo C; Lemini C; García-Mondragón J; de la Peña A; Jayme V; Mendoza-Patiño N; Zavala E; Silva G; Blickenstaff RT; Fernández JM
Steroids; 1990 Feb; 55(2):83-6. PubMed ID: 2326832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
